Profile

For over 20 years, I have worked primarily with issues linked to intellectual property law and commercial transactions, and with technology-intensive companies and their legal issues in general.

I have national responsibility for and lead Setterwalls’ Life Sciences team, and am in the same way responsible for trademark and marketing law issues. I am experienced at handling i.a. patent- and trademark litigation where issues are dealt with in several jurisdictions in parallel. Sectors where I have particularly relevant experience include pharmaceuticals and medtech, foods and high-technology companies in general. My experience as general counsel at a Swedish listed company in the biometrics sector and as previous Managing Partner at Setterwalls has given me valuable insights into the needs of clients, from the client’s viewpoint. Commercial contracts, including those in an international environment, constitute an exciting and stimulating part of my everyday work. I regard understanding the client’s business and goals as necessary for being able to deliver to the point and pragmatic advice. All in.

Språk: English, Swedish, Swedish

Karriär

2006-

Setterwalls

2005

Precise Biometrics, general counsel

2000-2005

Setterwalls

1999

Advokatfirman Lindahl

1999

Lund University, LL.M.

1999

University of California, Santa Barbara (UCSB), research studies

1993

Swedish Naval Academy

Rekommendationer

  • “Per Lidman is a leader in his field. He is set apart from his competition.”

    Legal 500

  • “Per Lidman is very knowledgeable, responsive and highly practical.”

    Chambers & Partners

  • “Per Lidman is a solid, 'no frills' lawyer who delivers.”

    Chambers & Partners

  • “He offers comprehensive enforcement services to high-profile players in the pharmaceutical, e-commerce and food industries.”

    IAM Patent

  • “With nearly three decades of contentious and commercial expertise, Per Lidman combines deep legal knowledge with a well-established global network.”

    IAM Patent

  • “Per is clearly very experienced and offers pragmatic and commercially aware advice, rather than just focusing on legal procedures.”

    Chambers Europe

  • “Per is clearly very experienced and offers pragmatic and commercially aware advice, rather than just focusing on legal procedures.”

    Chambers Europe

  • “Per is clearly very experienced and offers pragmatic and commercially aware advice, rather than just focusing on legal procedures.”

    Chambers Global

  • “Per Lidman is responsive and has a strong commercial sense.”

    Chambers Global

  • “A tenacious litigator with in-depth expertise in handling strategic and commercial matters, Per boasts truly profound knowledge of local and international laws and policy”

    World Trademark Review

  • “His diligence, accessibility and deep well of IP knowledge, particularly in the pharmaceuticals sector”, are of great benefit to his clients.”

    IAM Patent

  • “Per is one of the most proactive and solution-oriented lawyers I have ever worked with. IAM Patent”

    IAM Patent

  • “Combines deep knowledge of patent law and a great technical understanding across various sectors to assist a diverse clientele.”

    IAM Patent 1000

  • “He has a deep technical understanding and his litigation skills are most impressive; he fights hard for his clients, never gives in and is lovely to work with.”

    IAM Patent

  • “Per Lidman’s advice was highly appreciated and he was very solution oriented”

    Legal 500

  • “Per Lidman who is the lead IP lawyer we use is very knowledgeable, has pragmatic suggestions to solutions to save time, is very likeable and our dialogue is always exceptionally pleasant.”

    Legal 500

  • “He understands his clients’ needs straight off the bat, courtesy of his refined commercial nous, and gets the job done.”

    IAM Patent

  • “Per Lidman maintains a vibrant litigation and transactions practice that cements Setterwalls´ position on the IP map. No cross-border mandate is too complex for Per, he´s an agile problem solver with impeccable coordination skills.”

    World Trademark Review

  • “Per Lidman is very professional and his work integrity is admirable.”

    Legal 500

  • “He is super experienced, friendly and brilliant at what he does.”

    World Trademark Review

  • “The dedicated and passionate Lidman has additionally been lighting up the life sciences space by brokering major R&D and licensing deals.”

    IAM Patent

  • “Lidman’s former stint as general counsel at a listed biometrics company stands him in good stead when managing portfolios and acting in hard-hitting pharmaceutical litigation”

    World Trademark Review

  • “Per Lidman is a reliable source of support and information in parallel import scenarios. His knowledge on the topic is always current and extremely vast.”

    World Trademark Review

  • “Heading its growth across the board, Per Lidman is a shrewd operator – accessible, straight-talking and knowledgeable” in both high-stakes altercations and in patent due diligence and contractual matters.”

    I AM Patent

  • “Transactional matters and litigation briefs are handled with particular finesse by Per Lidman, who attracts enthusiastic feedback from peers across the Nordic region.”

    World Trademark Review

  • “A former general counsel at a listed biometrics company, he understands the business implications of his actions and puts that to good use representing clients in patent and trademark disputes.”

    World Trademark Review

  • “Solid attorney at law with a uniquely thorough approach” och 'a delightful working partner”

    I AM Patent

  • “Per has a remarkable ability to always find the right path to winning a case.”

    Client Choice

  • “He is a proactive lawyer; he creates a feeling of reassurance that the matter is always under control.”

    Client Choice

  • “Per has strong knowledge, high integrity and the right attitude; he always delivers.”

    Client Choice

  • “I would trust Per to handle any matter that comes his way.”

    World Trademark Review

  • “Per Lidman is responsive and has a strong commercial sense”

    Chambers Europe

Case

Case | 18 Nov 2025

Setterwalls has successfully represented a pharmaceutical company in a patent dispute before the Patent and Market Court of Appeal

Read more
Case | 25 Mar 2024

Setterwalls advises Amniotics in connection with public takeover bid

Read more
Case | 18 Mar 2024

Setterwalls has advised Asgard Therapeutics AB in connection with a EUR 30 million Series A financing

Read more
Case | 30 Jan 2024

Setterwalls has successfully represented a pharmaceutical company in a patent dispute before the Patent and Market Court

Read more
Case | 27 Jan 2023

Patent on playground swings was found invalid

Read more
Case | 07 Jul 2022

Setterwalls has advised Respiratorius and Arcede Pharma in connection with a rights issue and Lex Asea distribution of shares

Read more
Case | 23 May 2022

Setterwalls has advised inriver AB in connection with a major growth investment from Thomas H. Lee Partners (THL)

Read more
Case | 06 Jul 2021

Setterwalls has advised Amniotics AB (publ) in connection with listing on Nasdaq First North Growth Market

Read more
Case | 02 Jul 2021

Setterwalls assists Aurena Laboratories in deal value of 70 million euro

Read more
Case | 08 Mar 2021

Setterwalls has assisted the Fristads Kansas Group in the sale of Fristads, Kansas and Leijona to Hultafors Group AB

Read more
Case | 06 Nov 2020

Setterwalls advises inRiver in connection with private placement of approximately SEK 285 million

Read more
Case | 13 Mar 2019

Setterwalls has assisted Ascelia Pharma in this year’s first listing at Nasdaq Stockholm

Read more
Case | 22 Nov 2018

Setterwalls has advised EQL Pharma in connection with oversubscribed rights issue

Read more
Case | 18 Jun 2018

Setterwalls acted for Orifarm in parallel trade case

Read more
Case | 01 Jun 2018

Setterwalls advisor to Fox Networks Group in an agreement on the launch of National Geographic+ as part of Telia’s offering

Read more
Case | 21 Jun 2017

Setterwalls assists BONESUPPORT in connection with listing on Nasdaq Stockholm

Read more
Case | 07 Sep 2016

Setterwalls has assisted Cloetta in connection with the development and launch of the app Let’s Talk

Read more
Case | 14 Jun 2016

Setterwalls advisor in revocation of pharma patent

Read more
Case | 02 Jun 2016

Setterwalls assists when Skandia Fastigheter acquires a property located in the city centre of Malmö

Read more
Case | 10 Jun 2014

Setterwalls assists LIDDS in connection with fundraising and listing on NASDAQ OMX First North

Read more
Case | 27 Mar 2014

Setterwalls advised Diligentia in the sale of development rights to Hökerum Bygg.

Read more
Case | 30 Jun 2011

Setterwalls assists in connection with a MSEK 120 investment round in Bonesupport

Read more

Artiklar

Has it become harder to obtain patent and specifically supplementary protection for pharmaceutical combination products?
News | 22 May 2026

Has it become harder to obtain patent and specifically supplementary protection for pharmaceutical combination products?

Läs nyhet
The Swedish Food Agency is reducing the regulatory burden for food businesses
News | 22 May 2026

The Swedish Food Agency is reducing the regulatory burden for food businesses

Läs nyhet
The EU pharma package: how close is it to becoming law?
News | 22 May 2026

The EU pharma package: how close is it to becoming law?

Läs nyhet
The Swedish Medical Products Agency is stepping up its market surveillance of e-commerce in medical devices
News | 14 Apr 2026

The Swedish Medical Products Agency is stepping up its market surveillance of e-commerce in medical devices

Läs nyhet
Setterwalls Receives Gold Ranking in World Trademark Review
News | 29 Jan 2026

Setterwalls Receives Gold Ranking in World Trademark Review

Läs nyhet
EU Court clarifies front‑of‑pack nutrition labelling for foods for special medical purposes: per‑portion figures included in such labelling constitute a prohibited repetition
News | 24 Nov 2025

EU Court clarifies front‑of‑pack nutrition labelling for foods for special medical purposes: per‑portion figures included in such labelling constitute a prohibited repetition

Läs nyhet
When legal and important areas of interest collide – the impact of patent law on interchangeability
News | 22 May 2025

When legal and important areas of interest collide – the impact of patent law on interchangeability

Läs nyhet
Setterwalls Gold ranked by the World Trademark Review
News | 05 Feb 2025

Setterwalls Gold ranked by the World Trademark Review

Läs nyhet
The Swedish Supreme Administrative Court seeks guidance from the CJEU on the interpretation of the provisions of EU law on the labelling of food for special medical purposes
News | 29 May 2024

The Swedish Supreme Administrative Court seeks guidance from the CJEU on the interpretation of the provisions of EU law on the labelling of food for special medical purposes

Läs nyhet
Recent developments and an update on Geographical Indications (GIs)
News | 29 May 2024

Recent developments and an update on Geographical Indications (GIs)

Läs nyhet
ICLG Patents 2023: Practical cross-border insights into patent law
News | 11 Oct 2022

ICLG Patents 2023: Practical cross-border insights into patent law

Läs nyhet
UPC opens its doors from 1 April 2023
News | 10 Oct 2022

UPC opens its doors from 1 April 2023

Läs nyhet
UP/UPC Update: The UPC Agreement may enter into force already in the autumn of 2022
News | 20 Jan 2022

UP/UPC Update: The UPC Agreement may enter into force already in the autumn of 2022

Läs nyhet
ICLG: Patent Law and Regulations 2022. Setterwalls’ experts explain Swedish patent law in the latest edition.
News | 22 Sep 2021

ICLG: Patent Law and Regulations 2022. Setterwalls’ experts explain Swedish patent law in the latest edition.

Läs nyhet
Recent news in international trade in food
News | 24 May 2021

Recent news in international trade in food

Läs nyhet
Nutrition and health claims in trademarks and product names – the transitional rule expires
News | 15 Mar 2021

Nutrition and health claims in trademarks and product names – the transitional rule expires

Läs nyhet
Life Sciences Report November 2020
News | 12 Nov 2020

Life Sciences Report November 2020

Läs nyhet
Placing a medical app on the Swedish market
News | 11 Nov 2020

Placing a medical app on the Swedish market

Läs nyhet
Is your product or service sustainable and can you truly say that you are carbon neutral?
News | 07 Oct 2020

Is your product or service sustainable and can you truly say that you are carbon neutral?

Läs nyhet
Setterwalls' experts explain patent litigation law in Sweden in this years’ edition of ICLG: Patents 2021
News | 24 Sep 2020

Setterwalls' experts explain patent litigation law in Sweden in this years’ edition of ICLG: Patents 2021

Läs nyhet
Life Sciences Report May 2020
News | 26 May 2020

Life Sciences Report May 2020

Läs nyhet
How to use your IP in times of crisis – 8 ideas to turn hardship into opportunity
News | 11 May 2020

How to use your IP in times of crisis – 8 ideas to turn hardship into opportunity

Läs nyhet
Life Sciences Report November 2019
News | 28 Nov 2019

Life Sciences Report November 2019

Läs nyhet
Dos and Don’ts when marketing pharmaceuticals in Sweden
News | 08 Oct 2019

Dos and Don’ts when marketing pharmaceuticals in Sweden

Läs nyhet
Setterwalls' experts explain patent litigation law in Sweden
News | 07 Oct 2019

Setterwalls' experts explain patent litigation law in Sweden

Läs nyhet
UP/UPC Update: Recruitment of judges reopens
News | 29 May 2019

UP/UPC Update: Recruitment of judges reopens

Läs nyhet
UP/UPC Update: Premises of the Paris seat of the Court of First Instance are displayed
News | 24 May 2019

UP/UPC Update: Premises of the Paris seat of the Court of First Instance are displayed

Läs nyhet
Patents on life?
News | 16 May 2019

Patents on life?

Läs nyhet
New EU regulation refuses certain health claims
News | 15 Nov 2018

New EU regulation refuses certain health claims

Läs nyhet
Life Sciences Report November 2018
News | 01 Nov 2018

Life Sciences Report November 2018

Läs nyhet
Setterwalls' experts explain the basics of litigating and commercializing patents in Sweden
News | 23 Aug 2018

Setterwalls' experts explain the basics of litigating and commercializing patents in Sweden

Läs nyhet
Good to know about “best before” and “use by” dates
News | 22 May 2018

Good to know about “best before” and “use by” dates

Läs nyhet
New Measures to Help Food Companies Achieve Compliancy
News | 06 Nov 2017

New Measures to Help Food Companies Achieve Compliancy

Läs nyhet
The status and future of the Unified Patent Court
News | 06 Nov 2017

The status and future of the Unified Patent Court

Läs nyhet
New rules regarding labelling of alcoholic beverages may be on the way
News | 17 May 2017

New rules regarding labelling of alcoholic beverages may be on the way

Läs nyhet
Life Sciences Report May 2017
News | 16 May 2017

Life Sciences Report May 2017

Läs nyhet
Life Sciences Report November 2016
News | 21 Nov 2016

Life Sciences Report November 2016

Läs nyhet
The McTrademark doctrine
News | 02 Nov 2016

The McTrademark doctrine

Läs nyhet
“Active Bacteria” an Illegal Health Claim
News | 17 May 2016

“Active Bacteria” an Illegal Health Claim

Läs nyhet
Life Sciences Report May 2016
News | 10 May 2016

Life Sciences Report May 2016

Läs nyhet
Life Sciences Report November 2015
News | 25 Nov 2015

Life Sciences Report November 2015

Läs nyhet
Using alternative intellectual property rights to maintain and defend market share beyond patent protection for pharmaceuticals
News | 01 Nov 2015

Using alternative intellectual property rights to maintain and defend market share beyond patent protection for pharmaceuticals

Läs nyhet
Trademarks Basics
News | 01 Nov 2015

Trademarks Basics

Läs nyhet
IP Tech Report Summer 2015
News | 22 Jun 2015

IP Tech Report Summer 2015

Läs nyhet
Swedish Dairy vs. Oatly – who is crying over spilled milk?
News | 01 Jun 2015

Swedish Dairy vs. Oatly – who is crying over spilled milk?

Läs nyhet
Life Sciences Report May 2015
News | 20 May 2015

Life Sciences Report May 2015

Läs nyhet
How do you behave from a legal perspective in an open innovation environment?
News | 01 May 2015

How do you behave from a legal perspective in an open innovation environment?

Läs nyhet
Life Sciences Report November 2014
News | 28 Nov 2014

Life Sciences Report November 2014

Läs nyhet
Distance selling of alcoholic beverages to Sweden: Who may pour the wine?
News | 01 Nov 2014

Distance selling of alcoholic beverages to Sweden: Who may pour the wine?

Läs nyhet